Raleigh, NC, United States of America

Eric J Gaukel

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Eric J Gaukel

Introduction

Eric J Gaukel is an accomplished inventor based in Raleigh, NC (US). He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary arterial hypertension. His innovative approach has led to the development of a unique dosage regimen that aims to improve patient outcomes.

Latest Patents

Eric J Gaukel holds a patent for a dosage regime and method for treating pulmonary arterial hypertension. This patent outlines a daily dosage regimen that consists of two discrete dosage forms. Each dosage form contains an amount ranging from about 600 mg to about 800 mg of a specific compound designed to treat this condition. The patent also includes methods for reducing serotonin biosynthesis and achieving specific pharmacokinetic parameters, which are crucial for effective treatment.

Career Highlights

Gaukel's career is marked by his dedication to advancing medical treatments. He is currently associated with Altavant Sciences GmbH, where he continues to work on innovative solutions for pulmonary arterial hypertension. His expertise and commitment to research have positioned him as a key figure in his field.

Collaborations

Eric has collaborated with notable colleagues, including Michelle Palacios and Stephen A Wring. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic strategies.

Conclusion

Eric J Gaukel's contributions to the field of medicine through his innovative patent demonstrate his commitment to improving treatment options for patients with pulmonary arterial hypertension. His work continues to inspire advancements in medical research and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…